Abstract |
Since the discovery of the first gastrointestinal hormones it has been intriguing to think that these defined chemical messengers may also influence the growth of tumors. Today, treatment with sex-hormones is well documented--and used in clinical practice--in prostatic (1,2), breast (3), endometrial, and ovarian carcinoma (4). Hormonal therapy ( progesterone) has also been tried with some success in renal carcinoma (5,6). Nevertheless, cancers of the gastrointestinal tract--colorectal, liver, stomach, and pancreatic, carcinoma, which constitute 25 percent of all malignancies in Scandinavia--are only treated by other means, mainly surgery, although there is substantial evidence today that these tumors can also be influenced by hormones.
|
Authors | A Andrén-Sandberg |
Journal | International journal of pancreatology : official journal of the International Association of Pancreatology
(Int J Pancreatol)
Vol. 4
Issue 4
Pg. 363-9
(May 1989)
ISSN: 0169-4197 [Print] United States |
PMID | 2659684
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Androgens
(physiology)
- Animals
- Female
- Humans
- Male
- Pancreatic Neoplasms
(physiopathology)
- Sex Factors
- Testosterone
(physiology)
|